MedPath

The Influence of Blood Sampling Technique on the Total Amount of Blood Collected for Laboratory Testing Critically Ill Pediatric Patients

Not Applicable
Not yet recruiting
Conditions
Iatrogenic Anaemia
Registration Number
NCT06376747
Lead Sponsor
Brno University Hospital
Brief Summary

The aim of this prospective randomized study is to evaluate blood loss caused by laboratory blood draws in patients in the paediatric ICU (Intensive Care Unit) of a tertiary hospital among two groups of patients with established long-term or mid-term intravenous access. In the first group, patients will undergo blood draws using the standard method. In the second group of patients, blood draws will be performed using a closed system.

Detailed Description

Anaemia is one of the most common comorbidities among patients hospitalized in intensive care units. Hospital-acquired anaemia (HAA) is a newly developed anaemia that occurs during hospitalization in patients who were not anaemic prior to admission. Patients with HAA have a higher risk of developing complications such as infections, muscle weakness, and neurocognitive developmental disorders; an increased incidence of blood and blood product transfusions (and related complications); longer hospital stays, and higher morbidity and mortality. According to available data, the incidence of anaemia in adults hospitalized in the ICU ranges from 40 to 74%. There a feq data describing anemia in critically ill pediatric patients, with the estimated incidence being up to 50%.

The etiology of HAA is multifactorial and is related to the severity of the underlying disease (sepsis, coagulation disorders, bleeding, renal failure, malnutrition, bone marrow suppression, decreased erythropoietin production, etc.). Another factor contributing to the development of anaemia in critically ill patients is iatrogenic blood loss caused by blood draws for laboratory testing.

In addition to the standard blood collection method, closed-loop sampling (in-line sampling) can also be used, with studies in adult patients showing a reduction in the amount of blood drawn, ranging from 20 to 80% after its implementation.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Signed informed consent for the study.
  • Patients with established intravenous access: CVC (Central Venous Catheter), CICC (Centrally Inserted Central Catheter), PICC (Peripherally Inserted Central Catheter), MVC (Midline Venous Catheter), venous port, from which blood can be drawn.
  • Anticipated length of stay in the ICU more than 24 hours
Exclusion Criteria
  • Age outside the specified range.
  • Peripheral venous access only.
  • Anticipated length of stay in the ICU less than 24 hours.
  • Organ donors.
  • Lack of consent from the legal representative/patient.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Average amount of blood collected for laboratory diagnostic purposesOn day 1,3,5,7,10,14 and 28 of patient stay at paediatric ICU

Average amount of blood collected for laboratory diagnostic purposes on days 1, 3, 5, 7, 10, 14, and 28 of hospitalization in two groups of patients subjected to different blood sampling techniques for laboratory testing

Secondary Outcome Measures
NameTimeMethod
Incidence of anaemia up to transfusion triggeron the day of patient' s discharge from paediatric ICU

haemoglobin levels below 70 g/l at any time during hospitalization

Trend of haemoglobin decline over timeOndays 1,3,5,7,10,14 and 28 of patient stay at paediatric ICU

Trend of haemoglobin decline over time, defined as the absolute value of haemoglobin

Incidence of anaemiaon the day of patient' s discharge from paediatric ICU

decrease in haemoglobin levels below 90 g/l at any time during hospitalization

Frequency of blood product transfusions and their quantityon the day of patient' s discharge from paediatric ICU

Frequency of blood product transfusions (erythrocytes, platelets, plasma, fibrinogen, and other coagulation factors) and their quantity relative to the patient's body weight and age

Absolute amount of blood drawn and blood used for laboratory testingOn the day of patient' s discharge from paediatric ICU

Absolute amount of blood drawn and blood used for laboratory testing, relative to the patient's body weight, age, and day of ICU hospitalization

Incidence of coagulopathyon the day of patient' s discharge from paediatric ICU

Incidence of coagulopathy defined as INR above 1.4 and/or aPTT above 1.5 and/or fibrinogen below 1.5 g/l

Incidence of catheter-related complicationson the day of patient' s discharge from paediatric ICU

Incidence of catheter-related complications catheter infections, catheter occlusion defined, accidental catheter withdrawal)

Cumulative amount of blood drawn per day of ICU hospitalizationOn the day of patient' s discharge from paediatric ICU

Cumulative amount of blood drawn, relative to the patient's body weight and age, per day of ICU hospitalization

Type and frequency of laboratory testson the day of patient' s discharge from paediatric ICU

Type and frequency of laboratory tests noted on daily basis by ICU nursing stuff

Time to catheter replacement in case of catheter exchangeon the day of patient' s discharge from paediatric ICU

Time to catheter replacement in case of catheter exchange (in days)

Trial Locations

Locations (1)

KDAR - department of pediatrics anesthesia and resuscitation

🇨🇿

Brno, Czechia

KDAR - department of pediatrics anesthesia and resuscitation
🇨🇿Brno, Czechia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.